# Treace Medical Concepts

Treace Medical Concepts is an Asset Manager based in Ponte Vedra, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Ponte Vedra, United States
- **Region:** North America
- **Address:** Ponte Vedra, FL, United States
- **Founded:** 2013
- **Assets under management:** Undisclosed
- **Website:** treace.com
- **LinkedIn:** https://www.linkedin.com/company/treace-medical-concepts-inc

## Regulatory record

- **Reports private funds:** No

## About

Treace Medical Concepts is focused on advancing the standard of care for Hallux Valgus (bunion) surgery. | Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction® system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion.

## Sectors

- Medical Devices

## People

- John T. Treace — CEO and Founder

## Questions

### How does Treace generate revenue and what is its commercial reach?

Treace sells its implants and instrumentation directly to hospitals, ambulatory surgery centers, and individual surgeons through a team of direct sales representatives in the United States. The company does not license its technology or operate through distributors. In 2023, it reported revenue of roughly $190 million, up from $143 million in 2022, driven by higher surgical volumes and an expanding active surgeon base.

### Who are Treace's main competitors in foot-and-ankle orthopedics?

Treace competes with the foot-and-ankle divisions of large orthopedic companies including Stryker, Arthrex, and Zimmer Biomet, as well as smaller focused players like Paragon 28 and CrossRoads Extremity Systems. The company differentiates by dedicating its entire R&D and sales effort to midfoot and forefoot surgery rather than offering a broad extremity portfolio.

### What is the regulatory status of Treace's product portfolio?

The Lapiplasty system received FDA 510(k) clearance in 2014 and its most recent clearance for expanded indications came in 2020. The Adductoplasty system for midfoot correction was cleared in 2022. All products are marketed under FDA Class II designations for bone fixation instrumentation.

## Related profiles

- [Braemar Hotels & Resorts](https://altss.com/profile/braemar-hotels-and-resorts-inc)
- [Proem Acquisition Corp. I](https://altss.com/profile/proem-acquisition-corp-i)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/treace-medical-concepts-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology